Fortitude Advisory Group L.L.C. Bristol Myers Squibb CO Transaction History

Fortitude Advisory Group L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $13,888 - $15,421	-218 Reduced 5.63%	3,654 $233,000
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $7,556 - $8,570	115 Added 3.06%	3,872 $268,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $136 - $162	2 Added 0.05%	3,757 $270,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $0 - $153	2 Added 0.05%	3,755 $267,000
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $4,357 - $4,798	60 Added 1.62%	3,753 $289,000
Q1 2022 May 25, 2022	SELL	$61.48 - $73.72 $12,541 - $15,038	-204 Reduced 5.23%	3,693 $270,000
Q4 2021 May 20, 2022	BUY	$53.63 - $62.52 $208,996 - $243,640	3,897 New	3,897 $243,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fortitude Advisory Group L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fortitude Advisory Group L.L.C. with notifications on news.